EPRX Competitors & Alternatives
Compare Eupraxia Pharmaceuticals Inc. Common Stock with similar stocks in the same industry
Biotechnology
EPRX
Main Stock$7.73
Tradestie Score
61
Market Cap
$307.12M
Analyst Upside
+111.5%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VSTM
Verastem, Inc.
|
$9.21
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.05
|
$540.97M | - | 65 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.36
|
$529.35M | 11.4 | 62 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.56
|
$512.39M | - | 67 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.88
|
$505.12M | 2.8 | 60 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$98.19
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.04
|
$468.01M | - | 45 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$11.22
|
$463.20M | - | 43 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.41
|
$457.09M | - | 55 | Compare |
More EPRX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry